Compare Hinge Health Inc. Class A Common Stock (HNGE) vs iShares International Treasury Bond ETF (IGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs iShares International Treasury Bond ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while iShares International Treasury Bond ETF trades at $39.67 (market cap $1.31B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 6.5× iShares International Treasury Bond ETF's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, iShares International Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and iShares International Treasury Bond ETF for 92 Days on average.
| HNGE | IGOV | |
|---|---|---|
Market Cap | $8.48B | $1.31B |
Volume | 879,799 | 98,249 |
Sector | Health | Fixed Income |
52-Week High | $105.14 | $42.99 |
52-Week Low | $31.17 | $39.58 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $8.10B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
IGOV trades at $39.67, showing modest daily gains of 0.23% amid bearish technical signals. The stock faces selling pressure with moving averages indicating a downtrend, though oscillators suggest potential near-term momentum. Recent news highlights rising global bond yields creating headwinds for financial markets, while the company's key financial ratios remain undisclosed in current data.
The outlook remains cautious with technical indicators favoring bearish sentiment. Investment opportunities depend on improved fundamental metrics and market stabilization, while risks include persistent bond yield pressures and lack of clear profitability data. Stock investors should await clearer financial performance indicators before establishing positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →
